0001144204-16-088278.txt : 20160315 0001144204-16-088278.hdr.sgml : 20160315 20160315175746 ACCESSION NUMBER: 0001144204-16-088278 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160311 FILED AS OF DATE: 20160315 DATE AS OF CHANGE: 20160315 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edge Therapeutics, Inc. CENTRAL INDEX KEY: 0001472091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264231384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1600 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 800-208-3343 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1600 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HEALY JAMES CENTRAL INDEX KEY: 0001245624 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37568 FILM NUMBER: 161508109 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD, 4-250 CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 v434318_4.xml OWNERSHIP DOCUMENT X0306 4 2016-03-11 0 0001472091 Edge Therapeutics, Inc. EDGE 0001245624 HEALY JAMES C/O SOFINNOVA 000 SAND HILL ROAD, BLDNG 4, SUITE 250 MENLO PARK CA 94025 1 0 0 0 Common Stock 2016-03-11 4 P 0 541343 7.2997 A 2852711 I By Fund Consists of 2,852,711 shares of common stock owned of record by Sofinnova Venture Partners IX, L.P. ("SVP IX"). The Reporting Person is a managing member of Sofinnova Management IX, L.L.C., the general partner of SVP IX, and as such, may be deemed to share voting and investment power with respect to such shares. The Reporting Person disclaims beneficial ownership with regard to such shares, except to the extent of his proportionate pecuniary interest therein. /s/ Nathalie Auber, attorney in fact 2016-03-15